What might the psychobiology of posttraumatic stress disorder teach us about future approaches to pharmacotherapy?

Journal of Clinical Psychiatry

Volumn 61, Issue SUPPL. 7, 2000, Pages 44-51

  Friedman, Matthew J ^a  

^a Department of Veterans Affairs Regional Office White River Junction   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; NEUROPEPTIDE Y RECEPTOR AGONIST; SUBSTANCE P ANTAGONIST;

DRUG EFFECT; DRUG INDICATION; HUMAN; PATHOPHYSIOLOGY; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOBIOLOGY; REVIEW;

CORTICOTROPIN-RELEASING HORMONE; DRUG DESIGN; ENDORPHINS; GLUTAMIC ACID; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; NEUROPEPTIDE Y; PITUITARY-ADRENAL SYSTEM; SEROTONIN; STRESS; STRESS DISORDERS, POST-TRAUMATIC; SUBSTANCE P; SYMPATHETIC NERVOUS SYSTEM; THYROID HORMONES;

EID: 0034095912     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Friedman MJ. Progress in Psychobiological Research on PTSD. Seminars in Clinical Neuropsychiatry. Philadelphia, Pa: WB Saunders; 1999
2. Yehuda R. Biology of posttraumatic stress disorder. J Clin Psychiatry 2000; 61(suppl 7):14-21
3. Friedman MJ. Current and future drug treatment for posttraumatic stress disorder patients. Psychiatr Ann 1998;28:461-468
4. Bremner JD, Licinio J, Darnell A, et al. Elevated CSF corticotropin-releasing factor concentrations in post-traumatic stress disorder. Am J Psychiatry 1997;154:624-629
5. Stout SC, Kilts CD, Nemeroff CB. Neuropeptides and stress: preclinical findings and implications for pathophysiology. In: Friedman MJ, Charney DS, Deutch AY, eds. Neurobiological and Clinical Consequences of Stress; From Normal Adaptation to PTSD. Philadelphia, Pa: Lippincott-Raven; 1995:103-123
6. Morgan CA, Wang S, Southwick SM, et al. Plasma NPY in humans experiencing acute uncontrollable stress. Biol Psychiatry. In press
7. Southwick SM, Paige SR, Morgan CA, et al. Adrenergic and serotonergic abnormalities in PTSD: catecholamines and serotonin. Semin Clin Neuropsychiatry 1999;4:242-248
8. Cannon WB. The Wisdom of the Body. New York, NY: Norton; 1932
9. Aston-Jones G, Valentino R, Van Bocksteele. Locus coeruleus, stress, and PTSD: neurobiological and clinical parallels. In: Murburg MM, ed. Catecholamine Function in Posttraumatic Stress Disorder: Emerging Concepts. Washington, DC: American Psychiatric Press; 1994:17-62
10. Shalev A, Freedman SA, Peri T, et al. Prospective study of posttraumatic stress disorder and depression following trauma. Am J Psychiatry 1998; 155:630-637
11. Gold PE, McCarty RC. Stress regulation of memory processes: role of peripheral catecholamines and glucose. In: Friedman MJ, Charney DS, Deutch AY, eds. Neurobiological and Clinical Consequences of Stress: From Normal Adaptation to PTSD. Philadelphia, Pa: Lippincott-Raven; 1995:151-162
12. Cahill L. A neurobiological perspective on emotionally influenced, long-term memory. Semin Clin Neuropsychiatry 1999;4:266-273
13. Southwick SM, Krystal JH, Bremner JD, et al. Noradrenergic and serotonergic function in posttraumatic stress disorder. Arch Gen Psychiatry 1997; 54:749-758
14. Pitman R, Shalev AY, Orr SP. Posttraumatic stress disorder: emotion, conditioning, and memory. In: Gazzaniga MS. ed. The New Cognitive Neurosciences, 2nd ed. Cambridge, Mass: MIT Press; 2000:1133-1147
15. Cahill L. The neurobiology of emotionally influenced memory: implications for the treatment of traumatic memory. Ann N Y Acad Sci 1997;821: 238-246
16. Famularo R, Kinscherff R, Fenton T. Propranolol treatment for childhood post-traumatic stress disorder, acute type: a pilot study. Am J Dis Child 1988;142:1244-1247
17. Friedman MJ, Southwick SM. Towards pharmacotherapy for PTSD. In: Friedman MJ, Charney DS, Deutch AY, eds. Neurobiological and Clinical Consequences of Stress: From Normal Adaptation to PTSD. Philadelphia, Pa: Lippincott-Raven; 1995:465-481
18. Kinzie JD, Leung P. Clonidine in Cambodian patients with posttraumatic stress disorder. J Nerv Ment Dis 1989;177:546-550
19. Selye H. The general adaptation syndrome and the diseases of adaptation. J Clin Endocrinol 1946;6:117-230
20. Yehuda R, Southwick SM, Krystal JH. Enhanced suppression of cortisol following a low dose of dexamethasone in combat veterans with posttraumatic stress disorder. Am J Psychiatry 1993:150:83-86
21. Pearlstein T. Antidepressant treatment of posttraumatic stress disorder. J Clin Psychiatry 2000;61(suppl 7):40-43
22. Pitman RK, van der Kolk BA, Orr SP, et al. Naloxone-reversible analgesic response to combat-related stimuli in post traumatic stress disorder. Arch Gen Psychiatry 1990; 47:541-544
23. Glover H. A preliminary trial of nalmefene for the treatment of emotional numbing in combat vererans with post-traumatic stress disorder. Isr J Psychiatry Relat Sci 1993:30:255-263
24. Mason JW, Wang S, Yehuda R, et al. Some approaches to the study of the clinical implications of thyroid alterations in post-traumatic stress disorder. In: Friedman MJ, Charney DS, Deutch AY, eds. Neurobiological and Clinical Consequences of Stress: From Normal Adaptation to PTSD. Philadelphia, Pa: Lippincott-Raven; 1995:367-380
25. 3 levels and their association with symptoms in World War II veterans with combat-related posttraumatic stress disorder: replication of findings in Vietnam combat veterans. Psychosom Med 1999; 61:131-138
26. Michelson D, Licinio J, Gold PW. Mediation of the stress response by the hypothalamic-pituitaiy-adrenal axis. In: Friedman MJ, Charney DS, Deutch AY, eds. Neurobiological and Clinical Consequences of Stress: From Normal Adaptation to PTSD. Philadelphia, Pa: Lippincott-Raven; 1995:225-238
27. Otsuka M, Yoshioka K. Neurotransmitter functions of mammalian tachykinins. Physiol Rev 1993;73:229-308
28. Rosen A, Brodin K, Eneroth P, et al. Short-term restraint stress and s.c. saline injection alter the tissue levels of substance P and cholecystokinin in the peri-aqueductal grey and limbic regions of rat brain. Acta Physiol Scand 1992;146:341-348
29. Kramer MS, Cutler N, Feighner J, et al. Distinct mechanism for antidepressant activity by blockade of central Substance P receptors. Science 1998; 281:1640-1645
30. Chambers RA, Bremner JD, Moghaddam B, et al. Glutamate and PTSD: toward a psychobiology of dissociation. Semin Clin Neuropsychiatry. 1999; 4:274-281
31. Foa EB, Kozak MJ. Emotional processing of fear: exposure to corrective information. Psychol Bull 1986;99:20-35
32. Brewin CR, Dalgleish T, Joseph S. A dual representational theory of posttraumatic stress disorder. Psychol Rev 1996;103:670-686
33. Krystal JH, Bennett A, Bremner JD, et al. Toward a cognitive neuroscience of dissociation and altered memory functions in post-traumatic stress disorder. In: Friedman MJ, Charney DS, Deutch AY, eds. Neurobiological and Clinical Consequences of Stress: From Normal Adaptation to PTSD. Philadelphia, Pa: Lippincott-Raven; 1995:239-270
34. Post RM, Weiss SRB, Smith MA. Sensitization and kindling: implications for the evolving neural substrate of PTSD. In: Friedman MJ, Charney DS, Deutch AY, eds. Neurobiological and Clinical Consequences of Stress: From Normal Adaptation to PTSD. Philadelphia, Pa: Lippincott-Raven; 1995:203-224
35. Post RM, Weiss SRB, Li H, et al. Sensitization components of posttraumatic stress disorder: Implications for therapeutics. Semin Clin Neuropsychiatry. 1999;4:282-294
36. Kolb LC, Burris BC, Griffiths S. Propranolol and clonidine in the treatment of the chronic post-traumatic stress disorders of war. In: van der Kolk BA, ed. Post-Traumatic Stress Disorder: Psychological and Biological Sequelae. Washington, DC: American Psychiatric Press; 1984:97-107